Arabia Saudita - inglese - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

jamjoom pharmaceuticals company, saudi arabia - memantine hydrochloride - film-coated tablet - 10 mg

Arabia Saudita - inglese - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

h. lundbeck, denmark - memantine hydrochloride - film-coated tablet - 20 mg

Arabia Saudita - inglese - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

tabuk pharmaceutical manufacturing co., saudi arabia - memantine hydrochloride - film-coated tablet - 10 mg

Arabia Saudita - inglese - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

tabuk pharmaceutical manufacturing company, saudi arabia - memantine hydrochloride - film-coated tablet - 10 mg

Stati Uniti - inglese - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - memantine hydrochloride (unii: jy0wd0ua60) (memantine - unii:w8o17sjf3t) - memantine hydrochloride 5 mg - memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the alzheimer’s type. memantine hydrochloride tablets are contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation. risk summary there are no adequate data on the developmental risk associated with the use of memantine hydrochloride in pregnant women. adverse developmental effects (decreased body weight, and skeletal ossification) were observed in the offspring of rats administered memantine during pregnancy at doses associated with minimal maternal toxicity. these doses are higher than those used in humans at the maximum recommended daily dose of memantine hydrochloride [see data] . in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. the background risk of major birth defects and miscarriage for the indicated populat

Singapore - inglese - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - memantine 8.31 mg eqv memantine hydrochloride - tablet, film coated - memantine 8.31 mg eqv memantine hydrochloride 10.000mg

Malta - inglese - Medicines Authority

1 a pharma gmbh - memantine hydrochloride 10 mg - film-coated tablet

Malta - inglese - Medicines Authority

1 a pharma gmbh - memantine hydrochloride 20 mg - film-coated tablet

Armenia - inglese - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

one pharma industrial pharmaceutical company societe anonyme - memantine (memantine hydrochloride) - tablets film-coated - 10mg

Malesia - inglese - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

synerrv sdn bhd - memantine hydrochloride -